USPTO serial 50212454
DNANEXUS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with DNANEXUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Francisco, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jessica G. McDonald
Jessica G. McDonald Schwegman Lundberg & Woessner P.A.PO Box 2938Minneapolis, MN 55402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for executing bioinformatics workflows and pipelines; Downloadable computer software for multiomic data exploration, cohort building, and multiomic data querying; Downloadable computer software using artificial intelligence (AI) for processing and analyzing genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data; Downloadable computer software using artificial intelligence (AI) for featurizing genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, hosting and deploying AI models, integrating with machine learning environments, and providing AI agents, all related to such data; Downloadable software using machine learning for processing and analyzing genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data; Downloadable software using machine learning for featurizing genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, hosting and deploying AI models, integrating with machine learning environments, and providing AI agents, all related to such data; Downloadable computer software applications for operating federated data networks, enabling secure collaboration, providing clean-room analytics, and providing controlled data sharing among organizations; Downloadable computer software for accessing an online marketplace for third-party software applications, AI models, knowledge bases, and data; Downloadable computer software for the storage, management, tracking, transfer, sharing, processing, ingestion, harmonization, enrichment, cataloging, querying, and analysis of genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, in the fields of scientific research, diagnostics, precision medicine, precision health, life sciences, pharmaceutical and biopharmaceutical research and development, clinical trials; Downloadable computer software for the storage, management, tracking, transfer, sharing, processing, ingestion, harmonization, enrichment, cataloging, querying, and analysis of genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, in the fields of healthcare and health systems, and government and population health programs, namely biobanks; Downloadable computer software for the storage, management, tracking, transfer, sharing, processing, and analysis of data for regulatory compliance, workflows, and approvals, in the fields of scientific research, diagnostics, precision medicine, precision health, life sciences, pharmaceutical and biopharmaceutical research and development, clinical trials, healthcare and health systems, and government and population health programs, namely biobanks | ACTIVE | — |
| 035 | On-line retail store services featuring third-party software applications, artificial intelligence models, knowledge bases, and data in the fields of scientific research, diagnostics, precision medicine, precision health, life sciences, pharmaceutical and biopharmaceutical research and development, clinical trials, healthcare and health systems, and government and population health programs, namely biobanks | ACTIVE | — |
| 041 | Educational services, namely, conducting classes, workshops, and training programs in the field of bioinformatics, omics data analysis, precision medicine, and the use of cloud-based data platforms; Providing online non-downloadable publications in the nature of training materials in the field of bioinformatics and omics data analysis | ACTIVE | — |
| 042 | Platform as a service (PAAS) featuring computer software platforms for the storage, management, tracking, transfer, sharing, processing, and analysis of data for regulatory compliance, workflows, and approvals, in the fields of scientific research, diagnostics, precision medicine, precision health, life sciences, pharmaceutical and biopharmaceutical research and development, clinical trials, healthcare and health systems, and government and population health programs, namely biobanks; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for data analytics; Research in the field of bioinformatics; Structural and functional analysis of genomes for scientific research purposes; DNA analysis services for scientific research purposes; Computer software installation and maintenance; Data migration services; Consulting services in the field of genetic science; Consultation services relating to computer software; Consulting services in the field of cloud computing; Data as a service (DAAS) services featuring software for the storage, management, tracking, transfer, sharing, processing, ingestion, harmonization, enrichment, cataloging, querying, and analysis of genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data; Providing a web hosting platform for the storage, management, tracking, transfer, sharing, processing, and analysis of data for regulatory compliance, workflows, and approvals, in the fields of scientific research, diagnostics, precision medicine, precision health, life sciences, pharmaceutical and biopharmaceutical research and development, clinical trials, healthcare and health systems, and government and population health programs, namely biobanks; Providing temporary use of on-line non-downloadable software for executing bioinformatics workflows and pipelines; Providing temporary use of on-line non-downloadable software for the processing, ingestion, harmonization, enrichment, cataloging, and querying of omics data, namely an omics data warehouse; Providing temporary use of on-line non-downloadable software for multiomic data exploration, cohort building, and multiomic data querying; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for processing and analyzing genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for featurizing genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, hosting and deploying AI models, integrating with machine learning environments, and providing AI agents, all related to such data; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for processing and analyzing genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, in the fields of scientific research, diagnostics, precision medicine, precision health, life sciences, pharmaceutical and biopharmaceutical research and development, clinical trials, healthcare and health systems, and government and population health programs, namely biobanks; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for featurizing data, hosting and deploying AI models, integrating with machine learning environments, and providing AI agents; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for featurizing genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, hosting and deploying AI models, integrating with machine learning environments, and providing AI agents, all related to such data; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for processing and analyzing genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data; Software as a service (SAAS) services featuring software using machine learning for featurizing data, hosting and deploying AI models, integrating with machine learning environments, and providing AI agents; Software as a service (SAAS) services featuring software using machine learning for featurizing genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, hosting and deploying AI models, integrating with machine learning environments, and providing AI agents, all related to such data; Software as a service (SAAS) services featuring software using machine learning for processing and analyzing genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data; Providing temporary use of on-line non-downloadable software for operating federated data networks, enabling secure collaboration among organizations, providing clean-room analytics, and providing controlled data sharing; Providing temporary use of on-line non-downloadable software for hosting, deploying, and accessing third-party software applications, AI models, knowledge bases, and data; Scientific and technological services, namely, , analysis of genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, in the field of scientific research, and for diagnostic, and treatment purposes; Scientific and technological services, namely, consulting services in the field of bioinformatics, genomics, and omics data analysis; Software as a service (SAAS) services featuring software for the storage, management, tracking, transfer, sharing, processing, ingestion, harmonization, enrichment, cataloging, querying, and analysis of genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, in the fields of healthcare and health systems, and government and population health programs, namely biobanks; Software as a service (SAAS) services featuring software for the storage, management, tracking, transfer, sharing, processing, ingestion, harmonization, enrichment, cataloging, querying, and analysis of genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, in the fields of scientific research, diagnostics, precision medicine, precision health, life sciences, pharmaceutical and biopharmaceutical research and development, clinical trials; Platform as a service (PAAS) featuring computer software platforms for the storage, management, tracking, transfer, sharing, processing, ingestion, harmonization, enrichment, cataloging, querying, and analysis of genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, and of data for regulatory compliance, workflows, and approvals, in the fields of scientific research, diagnostics, precision medicine, precision health, life sciences; Providing a web hosting platform for the storage, management, tracking, transfer, sharing, processing, ingestion, harmonization, enrichment, cataloging, querying and analysis of genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, in the fields of scientific research, diagnostics, precision medicine, precision health, life sciences, pharmaceutical and biopharmaceutical research and development, clinical trials; Providing a web hosting platform for the storage, management, tracking, transfer, sharing, processing, ingestion, harmonization, enrichment, cataloging, querying and analysis of genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, in the fields of healthcare and health systems, and government and population health programs, namely biobanks; Platform as a service (PAAS) featuring computer software platforms for the storage, management, tracking, transfer, sharing, processing, ingestion, harmonization, enrichment, cataloging, querying, and analysis of genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, and of data for regulatory compliance, workflows, and approvals, in the fields of pharmaceutical and biopharmaceutical research and development, clinical trials, healthcare; Platform as a service (PAAS) featuring computer software platforms for the storage, management, tracking, transfer, sharing, processing, ingestion, harmonization, enrichment, cataloging, querying, and analysis of genomic, multiomic, and other omics data, namely DNA sequencing, RNA, proteomic, single-cell, tumor-normal, ctDNA and cfDNA data, and associated clinical and phenotypic data, and of data for regulatory compliance, workflows, and approvals, in the fields of health systems, and government and population health programs, namely biobanks; Cloud computing featuring software for use in validated cloud computing environments that comply with GxP and government regulatory requirements, for use in regulated research and by government customers; Software as a service (SAAS) services featuring software for the storage, management, tracking, transfer, sharing, processing, and analysis of data for regulatory compliance, workflows, and approvals, in the fields of scientific research, diagnostics, precision medicine, precision health, life sciences, pharmaceutical and biopharmaceutical research and development, clinical trials, healthcare and health systems, and government and population health programs, namely biobanks; Providing temporary use of on-line non-downloadable software for hosting and deploying third-party artificial intelligence models | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 11, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 11, 2026 | NWAP | NEW APPLICATION ENTERED | — |